US Patent Issued to Mydecine Innovations Group on July 21 for "Aza-substituted psilocin analogs and methods of synthesizing the same" (Colorado, Connecticut Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,660, issued on July 21, was assigned to Mydecine Innovations Group Inc. (Denver).

"Aza-substituted psilocin analogs and methods of synthesizing the same" was invented by Denton W. Hoyer (West Haven, Conn.) and Robert F. Roscow (Longmont, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to novel chemical compositions of matter and their methods of synthesis, and in particular novel analogs of Psilocin having enhanced physical and pharmacokinetic characteristics."

The patent was filed on Feb. 15, 2024, under Application No. 18/443,025.

*For further information, including images, charts and tables, please visit: ...